SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
iCAD, Inc. (ICAD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 42/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ICAD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio5.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.21
Book Value / Share$0.00
Revenue / Share$0.74
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-2.07 |
$41.55M |
$-32.45M |
-78.1% |
| 2016 |
$-0.63 |
$26.34M |
$-10.1M |
-38.3% |
| 2017 |
$-0.87 |
$28.1M |
$-14.26M |
-50.7% |
| 2018 |
$-0.54 |
$25.62M |
$-9.02M |
-35.2% |
| 2019 |
$-0.74 |
$31.34M |
$-13.55M |
-43.2% |
| 2020 |
$-0.80 |
$29.7M |
$-17.61M |
-59.3% |
| 2021 |
$-0.45 |
$33.64M |
$-11.25M |
-33.4% |
| 2022 |
$-0.54 |
$27.94M |
$-13.66M |
-48.9% |
| 2023 |
$-0.27 |
$17.32M |
$-4.85M |
-28% |
| 2024 |
$-0.21 |
$19.61M |
$-5.62M |
-28.6% |
